Last checked at 
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Monday and not separately reported by Alliance News:
----------
Halma PLC - Amersham, England-based safety equipment company - Names Sharmila Nebhrajani as an independent non-executive director, effective from December 1. Nebhrajani will also be a member of Halma's audit, remuneration & nomination committees. She is currently a non-executive director at ITV PLC and Severn Trent PLC, and chair of the National Institute for Health & Care Excellence.
----------
Diurnal Group PLC - Cardiff, Wales-based pharmaceutical company - Reports the appointment of three new members to its board. Anders Harfstrand joins as non-executive chair, while Deborah Jorn and Jean-Michel Cossery join as non-executive directors, respectively, all with immediate effect. Following the appointment of Harfstrand as non-executive chair, Sam Williams, who has held the role of interim chair since March 2020, will resume his role as a non-executive director and board representative of IP Group PLC.
----------
Angle PLC - Guilford, England-based liquid biopsy company - Appoints Todd Druley to the newly created role of chief medical officer, based in the US. The company says Druley brings highly relevant clinical and business expertise to the planning, development and commercialisation of Angle's diagnostics offerings through its clinical laboratories, regulatory filings and pharma services. Druley held the position of chief medical officer at ArcherDX Inc, a genomic analysis company, before it was acquired by Invitae Corp.
----------
Surgical Innovations Group PLC - Leeds-based medical instrument manufacturing company - Promotes Charmaine Day as chief financial officer with immediate effect. She joined Surgical Innovations in 2012 as financial controller, beginning her career in finance for Eville & Jones Ltd and later as management accountant at Ellis Fairbank PLC. In addition, the company says it considers appropriate board structure to fulfill the future strategic and governance needs of the business. The outcome of this review concludes that the optimal structure is a board of five directors comprising three non-executive directors and two executive directors. As a result, two of the current directors, Alistair Taylor and Adam Power, have indicated their intention to step down from the board with effect from the end of 2021.
----------
Induction Healthcare Group PLC - London-based hospital IT systems provider - Appoints Guy Mitchell as chief financial officer, with immediate effect. He has spent the last ten years specialising in high growth, private equity and venture capital backed software/technology companies, typically businesses with software-as-a-service models and with a global reach and customer base.
----------
By Evelina Grecenko; evelinagrecenko@alliancenews.com
Copyright 2021 Alliance News Limited. All Rights Reserved.
